These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 33037656)

  • 1. Effect of recombinant human growth hormone on liver fat content in young adults with nonalcoholic fatty liver disease.
    Pan CS; Weiss JJ; Fourman LT; Buckless C; Branch KL; Lee H; Torriani M; Misra M; Stanley TL
    Clin Endocrinol (Oxf); 2021 Feb; 94(2):183-192. PubMed ID: 33037656
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of growth hormone therapy on liver enzyme and other cardiometabolic risk factors in boys with obesity and nonalcoholic fatty liver disease.
    Xue J; Liang S; Ma J; Xiao Y
    BMC Endocr Disord; 2022 Feb; 22(1):49. PubMed ID: 35216556
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The GH/IGF-1 Axis Is Associated With Intrahepatic Lipid Content and Hepatocellular Damage in Overweight/Obesity.
    Dichtel LE; Corey KE; Haines MS; Chicote ML; Kimball A; Colling C; Simon TG; Long MT; Husseini J; Bredella MA; Miller KK
    J Clin Endocrinol Metab; 2022 Aug; 107(9):e3624-e3632. PubMed ID: 35779256
    [TBL] [Abstract][Full Text] [Related]  

  • 4. AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY GUIDELINES FOR MANAGEMENT OF GROWTH HORMONE DEFICIENCY IN ADULTS AND PATIENTS TRANSITIONING FROM PEDIATRIC TO ADULT CARE.
    Yuen KCJ; Biller BMK; Radovick S; Carmichael JD; Jasim S; Pantalone KM; Hoffman AR
    Endocr Pract; 2019 Nov; 25(11):1191-1232. PubMed ID: 31760824
    [No Abstract]   [Full Text] [Related]  

  • 5. High Prevalence of Nonalcoholic Fatty Liver Disease Among Adolescents and Young Adults With Hypopituitarism due to Growth Hormone Deficiency.
    Kang SJ; Kwon A; Jung MK; Chae HW; Kim S; Koh H; Shin HJ; Kim HS
    Endocr Pract; 2021 Nov; 27(11):1149-1155. PubMed ID: 34126247
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship of IGF-1 and IGF-Binding Proteins to Disease Severity and Glycemia in Nonalcoholic Fatty Liver Disease.
    Stanley TL; Fourman LT; Zheng I; McClure CM; Feldpausch MN; Torriani M; Corey KE; Chung RT; Lee H; Kleiner DE; Hadigan CM; Grinspoon SK
    J Clin Endocrinol Metab; 2021 Jan; 106(2):e520-e533. PubMed ID: 33125080
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Relationship between the Growth Hormone/Insulin-like Growth Factor System and the Histological Features of Nonalcoholic Fatty Liver Disease.
    Chishima S; Kogiso T; Matsushita N; Hashimoto E; Tokushige K
    Intern Med; 2017; 56(5):473-480. PubMed ID: 28250290
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship between growth hormone deficiency and nonalcoholic fatty liver disease in patients with pituitary stalk interruption syndrome.
    Huang Q; Xu H; Wang X; Mao J; Yu B; Zhu Y; Zhang R; Sun B; Zhang J; Ji W; Ma W; Nie M; Wu X
    Clin Endocrinol (Oxf); 2022 Nov; 97(5):612-621. PubMed ID: 35384023
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pancreatic fat and β-cell function in overweight/obese children with nonalcoholic fatty liver disease.
    Pacifico L; Di Martino M; Anania C; Andreoli GM; Bezzi M; Catalano C; Chiesa C
    World J Gastroenterol; 2015 Apr; 21(15):4688-95. PubMed ID: 25914480
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ten years with biosimilar rhGH in clinical practice in Sweden - experience from the prospective PATRO children and adult studies.
    Lundberg E; Kriström B; Zouater H; Deleskog A; Höybye C
    BMC Endocr Disord; 2020 Apr; 20(1):55. PubMed ID: 32349731
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gender difference in insulin-like growth factor I response to growth hormone (GH) treatment in GH-deficient adults: role of sex hormone replacement.
    Span JP; Pieters GF; Sweep CG; Hermus AR; Smals AG
    J Clin Endocrinol Metab; 2000 Mar; 85(3):1121-5. PubMed ID: 10720049
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sensitivity to exogenous GH and reversibility of the reduced IGF-I gene expression in aging rats.
    Velasco B; Cacicedo L; Melian E; Fernández-Vázquez G; Sánchez-Franco F
    Eur J Endocrinol; 2001 Jul; 145(1):73-85. PubMed ID: 11415855
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A rationale for the treatment of short stature in children with the combination of recombinant human growth hormone (rhGH) and recombinant human insulin-like growth factor-I (rhIGF-I).
    Bright GM; Fierro-Renoy JF
    Growth Horm IGF Res; 2020 Jun; 52():101318. PubMed ID: 32252003
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Efficacy and safety of recombinant human growth hormone solution in children with growth hormone deficiency in China: a multicenter trial].
    Hou L; Luo XP; Du ML; Ma HM; Gong CX; Li YC; Shen SX; Zhao ZH; Liang L; Dong GP; Yan CY; Du HW
    Zhonghua Er Ke Za Zhi; 2009 Jan; 47(1):48-52. PubMed ID: 19573383
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gender differences in growth hormone response to exercise before and after rhGH administration and the effect of rhGH on the hormone profile of fit normal adults.
    Giannoulis MG; Boroujerdi MA; Powrie J; Dall R; Napoli R; Ehrnborg C; Pentecost C; Cittadini A; Jørgensen JO; Sonksen PH;
    Clin Endocrinol (Oxf); 2005 Mar; 62(3):315-22. PubMed ID: 15730413
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Failure to increase insulin-like growth factor-I synthesis is involved in the mechanisms of growth retardation of children with inherited liver disorders.
    Maghnie M; Barreca A; Ventura M; Tinelli C; Ponzani P; De Giacomo C; Maggiore G; Severi F
    Clin Endocrinol (Oxf); 1998 Jun; 48(6):747-55. PubMed ID: 9713564
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of recombinant human growth hormone (rhGH) supplementation on adipokines and C-reactive protein in obese subjects.
    Albert SG; Haas MJ; Mooradian AD
    Growth Horm IGF Res; 2007 Feb; 17(1):19-25. PubMed ID: 17118687
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of growth hormone deficiency and recombinant hGH (rhGH) replacement on the hypothalamic-pituitary-adrenal axis in children with idiopathic isolated GH deficiency.
    Giavoli C; Bergamaschi S; Ferrante E; Ronchi CL; Lania AG; Rusconi R; Spada A; Beck-Peccoz P
    Clin Endocrinol (Oxf); 2008 Feb; 68(2):247-51. PubMed ID: 17868384
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of recombinant human growth hormone with or without rosiglitazone on hepatic fat content in HIV-1-infected individuals: a randomized clinical trial.
    Kotler DP; He Q; Engelson ES; Albu JB; Glesby MJ
    Antivir Ther; 2016; 21(2):107-16. PubMed ID: 25536669
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Growth hormone, insulin-like growth factors and their binding proteins in adult hemodialysis patients treated with recombinant human growth hormone.
    Jensen PB; Hansen TB; Frystyk J; Ladefoged SD; Pedersen FB; Christiansen JS
    Clin Nephrol; 1999 Aug; 52(2):103-9. PubMed ID: 10480221
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.